Abstract Diabetic nephropathy is a major complication of diabetes and a leading cause of end-stage renal failure in many developed countries. The study aimed to evaluate the efficiency of certain drugs and melatonin in the treatment of nephropathy secondary to diabetes. Diabetes was induced in rats by a single intraperitoneal injection of streptozotocin (50 mg/kg body weight). Three days after induction of diabetes (460-500 mg/dl), rats were treated daily for 60 days with Rowatinex, melatonin, Rowatinex ? melatonin, Amosar (Losartan Potassium) (LSP) and LSP ? melatonin. The evaluations were made by measuring blood urea nitrogen (BUN), serum uric acid, serum creatinine, urine creatinine, creatinine clearance, nitric oxide, malondialdehyde, superoxide dismutase, glutathione, total antioxidant capacity, kidney injury molecule-1, heat shock protein-70, caspase-3, transforming growth factor b1, and DNA degradation by comet assay and total protein contents. The histopathological picture of the kidneys and pancreases was confirmed in our results. Diabetic rats showed drastic changes in all the measured parameters. Treatment with melatonin and the selected drugs revealed amelioration levels with variable degrees. In conclusion, the combination of LSP and melatonin had the most potent effect on treating the deleterious action of diabetes on rat kidney.
Introduction
Diabetic nephropathy (DN) is one of the most serious secondary consequences of diabetes, leading to end-stage renal disease [1] . Studies have shown that persistent high glucose levels in blood leads to increased oxidative stress, which is one of the causative factors of DN. Thus, a high blood glucose level is the main factor in the initiation and progression of DN [2] .
DN results in the alteration of various extracellular matrix (ECM) components of the kidney such as heparan sulfate (HS) [3] , laminin [4] and type IV collagen [5] . This manifests as increased or decreased levels in the serum and/or urine, which can serve as important markers for evaluating DN [6] . However, the stage at which these alterations start setting in is not known. Also, usually the question arises concerning what the duration of diabetes should be in experimental models, e.g., in rats, to observe nephropathic changes. This information is therefore essential to pinpoint the changes in relation to the duration of diabetes.
Slowing the progression of diabetic nephropathy includes optimizing glycemic control, controlling hypertension and using angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). Because ACE inhibitors and ARBs have been shown to decrease or slow the progression of complications in diabetes, it seems reasonable to use a medication from one of these two classes of antihypertensive drugs as a first-line agent in hypertensive patients who have diabetes without microalbuminuria [7] . N-acetyl-5-methoxytryptamin, known as melatonin, is a hormone synthesized in the pineal gland [8] . Its role is mediated through the activation of melatonin receptors [9] . Also, it acts as a pervasive and powerful antioxidant [10] as well as in the protection of nuclear and mitochondrial DNA [11] . In addition, it plays an important role in maintaining cellular homeostasis against cellular stresses; it inhibits apoptosis in immune cells [12] and prevents neuronal cell death [13] . Melatonin is categorized by the US Food and Drug Administration (FDA) as a dietary supplement [14] . As melatonin may cause harm in combination with certain medications or in the case of certain disorders, a doctor or pharmacist should be consulted before making a decision to take melatonin [15] .
Rowatinex is a pharmaceutical product containing seven essential amino acids, 31 % pinene, 15 % camphene, 10 % borneol, 4 % anethole, 4 % fenchone and 3 % cineole. After oral intake of Rowatinex, it is rapidly absorbed because of the presence of terpenes, which are lipid-soluble substances. Due to the pharmacologic effects of these terpenes, Rowatinex is thought to have beneficial effects on conservative stone management and to support medical expulsive therapy [16] . Antibacterial effects of Rowatinex were described by Cipriani and co-workers, with pinenes being the most potent antibacterial substance, followed by borneol and fenchone [17] . Rodent studies on pinenes have indicated that hydrocarbons in this chemical category participate in similar pathways of absorption, metabolism to polar oxygenated metabolites and excretion. As a combination of seven naturally available terpenes, Rowatinex seems to be an anti-inflammatory agent and to have the potential to promote and accelerate stone expulsion in the primary management of urolithiasis [16] , where an increased prevalence of nephrolithiasis has been reported in patients with diabetes.
The antihypertensive drug losartan potassium (LSP) acts by blocking the actions of angiotensin II of the renin-angiotensin-aldosterone system. It blocks the vasoconstrictor and aldosterone secreting effects of angiotensin II by antagonizing the binding of angiotensin II with its receptors [18] .
In the present study, we selected melatonin because of its role as a wide-spectrum antioxidant that can easily cross cell membranes of different organs. Although Rowatinex is also considered an antioxidant, its action as an anti-inflammatory agent and kidney stone breaker is well documented. The LSP drug seems to relieve the high blood pressure of the kidney, and its combination with Rowatinex and melatonin may attenuate the adverse side effects of diabetes on the kidney. Therefore, the focus of this article is to evaluate the therapeutic effect of these drugs and melatonin on improving renal disorders in diabetic rats.
Materials and methods

Chemicals
All chemicals used were of high analytical grade, products of Merck, Germany, and Sigma, USA. Amosar is the trade name of losartan potassium (LSP) (Amuon Pharamacoceutical Co., SAE, Egypt).
Animals and ethics
Seventy male Wistar strain albino rats (150-200 g) were obtained from the animal house of the National Research Centre, Dokki, Giza, Egypt. Rats were fed on a standard diet and had free access to tap water. They were kept for 2 weeks to become acclimatized to the environmental conditions. Anesthetic procedures and handling of animals complied with the ethical guidelines of the Medical Ethics Committee of the National Research Center in Egypt (approval no. 11063).
Experimental design
The rats were divided into seven groups (10 rats each). Group I served as control rats, group 2 was the diabetic rats, group 3 was diabetic rats treated with Rowatinex, group 4 was the diabetic rats treated with melatonin, group 5 was the diabetic rats treated with a combination of Rowatinex and melatonin, group 6 was the diabetic rats treated with LSP, and group 7 was the diabetic rats treated with LSP and melatonin.
Administration regimens
Diabetic rats were injected intraperitoneally with a single dose of streptozotocin (STZ) (50 mg/kg body weight) dissolved in 0.01 M citrate buffer immediately before use [19] . After injection, animals had free access to food and water and were given 5 % glucose solution to drink overnight to counter hypoglycemic shock [20] .
After 3 days of hyperglycemia (460-500 mg/dl), rats were daily injected with melatonin (200 lg/kg b.wt., ip) [21] , Rowatinex (300 mg/kg b wt., orally) [22] and its combination as well as LSP (2 mg/kg b. wt. orally) [23] and its combination with melatonin for 60 days.
Sample preparations
After 60 days of drug treatment, the animals were fasted overnight; urine samples were collected and centrifuged at 3000 rpm for 10 min, and the supernatants were stored at -80°C for the further determinations.
Blood samples were taken from each animal by puncture of the sublingual vein into sterilized tubes, and they stood for 10 min to clot. Serum was separated by centrifugation at 3000 rpm for 10 min and used for the biochemical analysis.
After blood collection, all rats were killed under ether anesthesia. The kidneys were immediately removed, weighed, homogenized in 0.9 N sodium chloride (1:10 w/v) and centrifuged at 4000 rpm for 15 min. The supernatant was collected and stored at -20°C for different biochemical determinations.
Biochemical analysis
The kidney function indices, blood urea nitrogen (BUN), uric acid, creatinine and creatinine clearance, were estimated using biodiagnostic kits (Biogamma, Stanbio, West Germany).
The nephropathy index, kidney injury molecule (KIM-1), heat shock protein 70 (HSP 70), caspase-3 and transforming growth factor-b1 (TGF-b1), were determined by using an ELISA kit (R&D, Minneapolis, MN).
The oxidative stress markers, malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD) and nitric oxide (NO), were evaluated using the methods of Buege and Aust [24] , Moron et al. [25] , Nishikimi et al. [26] and Moshage et al. [27] , respectively. The total antioxidant capacity (TAC) was estimated by using biodiagnostic kits (Biogamma, Stanbio, West Germany).
Serum and kidney total protein contents were estimated by the method of Bradford [28] .
The DNA fragmentation index was evaluateded using the comet assay technique as described by Karimi et al. [29] .
Histopathological analysis
Kidney and pancreas sections of all groups were stained with hematoxylin and eosin (H&E) to detect changes in cell architecture [30] .
Statistical analysis
All data were expressed as mean ± SD of ten rats in each group. Statistical analysis was carried out by oneway analysis of variance (ANOVA), using the Costat software computer program, accompanied by the least significance difference (LSD) between groups at p \ 0.05.
Results
The glucose level in diabetic rats was significantly increased by 528.00 % compared with the control group. Rats treated with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination showed significant decreases in blood glucose by 56 Blood urea nitrogen (BUN) in diabetic rats showed a significant increase of 133.00 % compared with the control group. In the treated groups, rats treated with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination showed a significant decrease in BUN levels of 54.10, 53.50, 50.10, 42.00 and 51.20 %, respectively. Hence, treatment showed improvement levels of 126.00, 125.00, 117.00, 98.00 and 119.00 %.
Regarding the serum uric acid level, diabetic rats showed a significant increase of 196.00 % compared with the control group. Treatment of diabetic rats with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination significantly decreased the uric acid level by 51 Concerning with serum creatinine level, the diabetic rats showed a significant increase of 535.00 %. Diabetic rats treated with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination had significantly increased serum creatinine levels of 202.00, 187.00, 211.00, 187.00 and 214.00 % compared with the rats in the diabetic group with percentages of improvement reaching to 65.90, 60.90, 69.00, 61.00 and 69.50 %.
Regarding the creatinine level in urine, diabetic rats showed a significant decrease of 67.40 %. Treatment of rats with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination significantly increases the creatinine levels by 2020.00, 187.00, 211.00, 187.87 and 214.00 %. Therefore, we observed amelioration levels of 65.90, 60.90, 69.00, 61.00 and 69.50 %, respectively.
Concerning the creatinine clearance level, diabetic rats showed a significant decrease of 88.40 %. Treatment of diabetic rats with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination significantly increased the creatinine clearance levels by 706.80, 472.60, 477.00, 520.50, 485.00 and 475.30 %, respectively, with improvement levels reaching 54.70, 55.20, 61.00, 56.00 and 55.00 % ( Table 2) .
Regarding the oxidative stress markers, the nitric oxide level in diabetic rats showed a significant increase of 127.00 %. Treatment of diabetic rats with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination significantly decreased the nitric oxide levels by 25.50, 37.47, 34.00, 44.70 and 51.00 %. Therefore, we observed amelioration levels of 58.00, 85.00, 77.00, 101.00 and 116.00 %, respectively. In addition, malondialdehyde showed a significant increase of 55.20 % in diabetic rats. Treatment with Rowatinex, melatonin, its combination, LSP, and the LSP and melatonin combination significantly decreased the MDA level by 20.60, 15.50, 18.00, 17.00 and 21.00 %, respectively, compared with the (Table 6) .
Regarding the histopathological analysis of the kidneys and pancreases in the present study, control rats showed more or less normal kidney and pancreatic architectures (Fig. 2a, b) .
Diabetic rats showed the renal cortex with high cellularity and obliterated the capsular space of most corpuscles. Proximal convoluted tubules showed destructed epithelial lining of cells. Obliterated and destructed epithelial lining of distal convoluted tubules was also seen. Pancreatic section from diabetic rats showed atrophic pancreatic islets of Langhans (Fig. 2c, d) .
Diabetic rats treated with Rowatinex showed high atrophy of the kidney and pancreatic architecture (Fig. 2e,  f) . Treatment with melatonin and the compilation of melatonin and Rowatinex showed enhancement of the Values between parentheses are % changes over the diabetic group
Combination of melatonin and certain drugs for treatment of diabetic nephropathy in… 419 normal shapes (Fig. 2g-j) . Treatment with LSP showed high atrophy of kidney and pancreatic structures (Fig. 2k,  l) , while treatment with LSP and melatonin showed mild enhancement of kidney and pancreatic structures (Fig. 2m,  n) . The detailed histological findings of both the kidney and pancreas are shown in Fig. 2a -n, which represents the histopathological features of all the experimental groups under investigation.
Discussion
Diabetes mellitus remains one of the age-old chronic diseases of the human race, and its frontiers are expanding daily [31] . STZ administration to mature rats induced a significant increase in glucose levels with a decrease in body weight. This was in accordance with the results of Haligur et al. [32] who observed a decrease in insulin levels after STZ induction that produced a cytotoxic model of diabetes very similar to type I DM. Streptozotocin damages the Î 2 cells of the islets of Langerhans in the pancreas [33] , where the main reason for cellular injury is hypoxia. An extracellular calcium increase in diabetes leads to cell damage and activates both plasma membrane and mitochondrial injuries, which are the main cell damage pathways. Cell death is the last stage of the cellular damage, and it can occur by apoptosis or necrosis, where caspase-3 is the main marker [34] . Treatments with different drugs ameliorate the blood glucose level by variable degrees, where the LSP and melatonin combination demonstrated the most potent effect.
It was further observed in the present study that administration of STZ (50 mg/kg body weight) caused DN with an increase in the blood urea nitrogen, serum creatinine level and serum uric acid level and reduced urine creatinine and creatinin clearance levels. Treatment with the selected drugs resulted in a reduction in blood urea nitrogen, serum creatinine level and serum uric acid, while urine creatinine and creatinine clearance levels were increased upon treatment. Parving et al. [18] showed that treatment with an antihypertensive drug provided a renoprotective effect in hypertensive patients with type 2 diabetes and microalbuminuria. In agreement with the results of Parving et al. [18] , we found that the combination of LSP and melatonin greatly improved the serum uric acid and urine creatinine levels.
It is well known that inflammation and oxidative stress play important roles in podocyte injury and downregulation of nephrin and podocin [35] . MDA is a marker of lipid peroxidation induced by oxidative stress, while SOD is an important defensive metalloproteinase that catalyzes the dismutation of superoxide radicals [36, 37] . In the present study, the increased MDA and NO levels and the decreased SOD, GSH and TAC levels indicated increased oxidative stress. Increased NO production was also found during chronic inflammation, suggesting the role of NO in the kidney response to inflammatory stimuli [38, 39] . Furthermore, oxidative stress could lead to proinflammatory cytokine production, which may further increase oxidative stress, setting up a vicious cycle [36] . Treatment with the selected drugs reverses the effect of diabetes on the oxidative marker levels, where the combination of LSP and melatonin greatly improved the NO, MDA, SOD and GSH levels.
Recently, several studies described the involvement of macrophages in the pathogenesis of diabetic nephropathy [40] . In line with this observation, we can speculate that b Fig. 2 a Kidney section of normal rats showed renal cortex with normal corpuscles, a normal glomerulus (black arrow), and a normal pattern of proximal convoluted (red arrow) and distal convoluted (yellow arrow) tubules. b Pancreatic section of normal rats showed atrophic pancreatic islets of Langhans (arrow). c Kidney section of diabetic rats showed renal cortex with corpuscles of high cellularity and obliterated capsular space (black arrow), proximal convoluted tubules (red arrow) and distal convoluted tubules (yellow arrow) with destructed epithelial lining cells. d Pancreatic section from diabetic rats showed atrophic pancreatic islets of Langhans (arrow). e Kidney section from diabetic rats treated with Rowatinex showed renal cortex with corpuscles of high cellularity and obliterated capsular space (black arrow), proximal convoluted tubules (red arrow) and distal convoluted tubules (yellow arrow) showing destructed epithelial lining cells. f Pancreatic section from the diabetic group treated with Rowatinex showed small-size pancreatic islets of Langerhans with regular and arranged shape (arrow). g Kidney section from the diabetic group treated with melatonin showed renal cortex of a renal corpuscle with normal glomerulus (black arrow) and normal pattern of proximal convoluted (red arrow) and distal convoluted (yellow arrow) tubules. h Pancreatic section from the diabetic group treated with melatonin showed almost normal sized pancreatic islets of Langhans with regular shape (arrow). i Kidney section from the diabetic group treated with Rowatinex and melatonin showed renal cortex of a renal corpuscle with normal glomerulus (black arrow) and a normal pattern of proximal convoluted (red arrow) and distal convoluted (yellow arrow) tubules. j Pancreatic section from the diabetic group treated with Rowatinex and melatonin showed vacuolations and necrosis of b-cells of islets of Langhans (arrow). k Kidney section from the diabetic group treated with LSP showed renal cortex with corpuscles of high cellularity and obliterated capsular space (black arrow) and proximal convoluted tubules (red arrow), and distal convoluted tubules (yellow arrow) showed destructed epithelial lining cells. l Pancreatic section from the diabetic group treated with LSP showed pancreatic islets of Langerhans with regular and arranged shape (arrow). m Kidney section from diabetic rats treated with LSP and melatonin showed renal cortex of normal corpuscles with mild cellularity and mildly obliterated capsular space (black arrow), normal proximal convoluted tubules (red arrow) and normal distal convoluted (yellow arrow) tubules. n Pancreatic section from diabetic rats treated with LSP and melatonin showed mildly atrophic pancreatic islets of Langhans (arrow). (H&E, 4009) infiltrated macrophages stimulate mesangial cells to secrete TGF-b1, which induces the production of extracellular matrix (ECM) proteins in an autocrine or paracrine manner. However, macrophages can secrete TGF-b1, which can stimulate mesangial cells to produce ECM proteins [40] . Thus, macrophages could stimulate mesangial cells to produce mesangial matrix directly and/or indirectly via TGF-b1 in the development of diabetic nephropathy [41] . TGF-b1 was improved after treatment with the chosen drugs by variable degrees, where LSP and melatonin showed the highest improvement level.
The KIM-1 in diabetic rats was significantly increased. In agreement with our results, Chaudhary et al. [42] stated that early renal tubular damage biomarker levels including urinary KIM-1 are elevated in diabetes, even in those with normoalbuminuria. Carlsson et al. [43] added that insulin sensitivity was inversely and independently associated with the KIM-1 concentration. Impaired insulin sensitivity and hyperinsulinemia have been suggested to contribute to the development of renal injury by promotion of mitogenic and fibrotic processes via activation of insulin-like growth factor-1, transforming growth factor-b, endothelin-1 and the rennin-angiotensin-aldosterone system [44] . Moreover, insulin resistance is associated with oxidative stress [45] , proinflammatory cytokines and adipokines [46] , which lead to renal injury. Contradictorily, increased inflammatory activity due to ongoing kidney damage could also impair insulin sensitivity [47] .
Tubulointerstitial injury is present in chronic kidney disease, and it seems to be a better predictor of disease progression and long-term prognosis than the glomerular damage [48] . By measuring the KIM-1 level, this ''tubular phase'' of renal damage could be detected before the development of albuminuria, the currently used marker of early diabetic nephropathy [44] . In the present study, treatment showed a significant decrease in the glomerular damage KIM-1 level. Vaidya et al. [49] confirmed our results by the observed regression of diabetic nephropathy after treatment due to the reduced levels of urinary KIM-1. The most pronounced level of improvement was recorded after treatment with the combination of LSP and melatonin.
Heat shock proteins (HSPs) are a family of proteins that are known to be highly conserved intracellular proteins and categorized according to their molecular weight [50] . It has been found that various sources of stress including thermal, oxidative, hemodynamic, osmotic and hypoxic stresses have the ability to induce the expression of various types of heat shock protein members including HSP70 to offer cytoprotection [51] . Barutta et al. [52] found that diabetes expressed HSP70 in the glomeruli and in the medulla, which may explain the ability of renal cells to increase the effectiveness of the cytoprotective response. Diabetes has oxidative properties, and thus HSP70 is well expressed.
Treatment with the selected drugs, especially the combination of LSP and melatonin, improved the level of HSP70 through their antioxidative effects and the resulting protein depression.
Caspases are cysteine-aspartyl-specific proteases that play a key role in apoptosis. Caspase-3 is one of the effector caspases of apoptotic pathways [32] . Gene targeting strategies have provided valuable tools to study the physiologic function of individual caspases in vivo and have shown their roles not only in apoptosis but also in other fundamental cellular processes [53] . Several in vitro studies have suggested that caspase-dependent apoptotic pathways are essential for b cell apoptosis [54] . The mechanisms of tubular changes in diabetic kidneys are unclear. One attractive mechanism is apoptosis, which has been demonstrated to mediate cell death in a variety of renal diseases, including diabetic nephropathy [55] . Indeed, apoptosis was detected in renal proximal tubular cells of different species including experimental animals and patients with diabetes, suggesting that tubular apoptosis may precede tubular atrophy [56] . Frances et al. [57] demonstrated that apoptosis occurring in the diabetic state was associated by elevation of OH that contributed partially to the mitochondrial cytochrome c release and elevation of caspase-3 activation. Treatment with the selected drugs, with special attention to the LSP and melatonin combination, attenuated the elevated free radicals, which improved the apoptotic condition.
Apoptosis is also mediated by DNA fragmentation [58, 59] , which is associated with a decrease in protein content. This decrease may be due to a decrease in ribosomal granules of the rough endoplasmic reticulum or to a decrease in DNA content [58] . These results fit with those of Szkudelski [59] , who stated that one of the targets of the reactive oxygen species is DNA of the pancreatic islets where its fragmentation takes place in b cells. These observations were confirmed by the observed increase in DNA tail lengths, the percentages of tailed DNA and the tail moment (the product of the tail length and the fraction of total DNA in the tail) in diabetic rats.
The comet assay technique in the present study is a commonly used method to detect oxidative damage in lymphocyte DNA, and the degree of oxidative stress is related to the size of the comet tail [60] . High blood glucose levels in vitro impair cellular DNA repair and increase DNA cleavage [61] . Hyperglycemia itself contributes to increased generation of ROS, and increased oxidative stress would lead to oxidative DNA damage. The same authors added that blockade of hyperglycemia-induced ROS production would reverse the adverse effect of diabetes on DNA structure. This was confirmed by the observed improvement in DNA degradation after treatment with the LSP and melatonin combination.
The histopathological picture of diabetic kidney in our study showed vacuolar degeneration in some of the tubular epithelial cells. There was an increase in the thickness of tubular epithelial cells with narrowing of the lumen, signs of degeneration in the form of karyolysis and karyorrhexis as well as deformation of the renal tissue architecture. These observations were in agreement with Shaffie et al. [62] . These vacuolations may be due to the altered permeability of the cell membrane, which would allow increasing the fluid uptake. Lannergren et al. [58] added that the presence of vacuoles was due to lactate accumulation in the tubules of the kidney resulting in increased osmotic pressure and subsequent water influx. In the pancreatic tissue, degeneration of islet cells was seen with moderate vacuolations. Rowatinex and LSP treatments showed mild destruction of the epithelial lining of the proximal and distal convoluted tubules, while treatment with melatonin and its combination with Rowatinex or Amosar showed a normal pattern of proximal and distal convoluted tubules. This amelioration was due to the antioxidant properties of melatonin [10] and Rowatinex [16, 17] and the renoprotective effect of LSP [18] .
In conclusion, diabetes had a deleterious effect on rats' kidney functions, nephropathy index, oxidative stress markers, DNA fragmentation, protein contents and kidney histopathological features. Treatment with the selected drugs improved the biochemical parameters by variable degrees. The combination of melatonin and LSP improved most of the biochemical parameters under investigation. Further studies are needed to explore the use of melatonin as a dietary supplement in the treatment of diabetic nephropathy.
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